Myomo Inc. — Earnings Quality Grade F
MYO · Healthcare
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 37 days, change -6 days YoY
AR growth 7.1% vs revenue growth 25.7%
Revenue grew 25.7% but CFFO declined -341.1%
Small-cap context: Small-cap revenue/CFFO ratio is sensitive to growth-stage working-capital draws.
Expense Quality
Inventory -1.4% vs COGS 49.9%. Normal
CapEx growth 145.1% is >2x revenue growth 25.7%
SG&A/Gross Profit = 127.7%, exceeds 70%
Gross margin swung -5.5pp (71.2% → 65.7%)
Cash Flow Quality
CFFO < Net Income for 3 consecutive years
Small-cap context: Small-cap CFFO/NI often diverges from working-capital swings, not necessarily manipulation.
FCF is negative ($-0.0B)
Accruals ratio = -2.7%. Low accruals
Cash $0.0B covers 95% of debt $0.0B
Balance Sheet Health
Goodwill+Intangibles $0.0B = 14% of equity. Manageable
Interest coverage = -31.9x (<2x). Financial stress
Other assets 10.6% vs revenue 25.7%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions negative for 3 years
Small-cap context: A single acquisition on a small balance sheet can trip serial-acquirer logic.
Insufficient data
Manipulation Score
M-Score = -1.53 (> -1.78). LIKELY MANIPULATOR
Small-cap context: Beneish M-Score was calibrated on large-caps; small-cap DSO/inventory volatility mechanically inflates it.
Portfolio monitoring
Monitor MYO continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25